Home

Oups Opinion agneau sep et vaccination pfizer Esquive Marin Immunité

KFF COVID-19 Vaccine Monitor: September 2021 | KFF
KFF COVID-19 Vaccine Monitor: September 2021 | KFF

Effectiveness of an inactivated Covid-19 vaccine with homologous and  heterologous boosters against Omicron in Brazil | Nature Communications
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM

Pfizer-biontech Covid-19 Vaccine
Pfizer-biontech Covid-19 Vaccine

Infections, hospitalisations, and deaths averted via a nationwide  vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19  vaccine in Israel: a retrospective surveillance study - The Lancet  Infectious Diseases
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study - The Lancet Infectious Diseases

Vaccines and Related Biological Products Advisory Committee – 9/17/2021 -  YouTube
Vaccines and Related Biological Products Advisory Committee – 9/17/2021 - YouTube

Evidence for safety of Pfizer-BioNTech's COVID-19 vaccine booster dose
Evidence for safety of Pfizer-BioNTech's COVID-19 vaccine booster dose

Covid-19 Vaccine Rollout Carries Lessons for Pharma Supply Chains, Says  Pfizer Executive - WSJ
Covid-19 Vaccine Rollout Carries Lessons for Pharma Supply Chains, Says Pfizer Executive - WSJ

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years:  Recommendations of the Advisory Committee on Immunization Practices —  United States, September 2021 | MMWR
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 | MMWR

Pfizer CEO confirms coronavirus vaccine trial may have results in October
Pfizer CEO confirms coronavirus vaccine trial may have results in October

Myths and Facts About the Vax — Debunking Common COVID-19 Vaccine Myths >  TRICARE Newsroom > Articles
Myths and Facts About the Vax — Debunking Common COVID-19 Vaccine Myths > TRICARE Newsroom > Articles

Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A  target trial emulation study in the U.S. Veterans Affairs healthcare system  - eClinicalMedicine
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine

COVID-19 Booster Shots are Now Available – What You Need to Know > TRICARE  Newsroom > Articles
COVID-19 Booster Shots are Now Available – What You Need to Know > TRICARE Newsroom > Articles

County-level vaccination coverage and rates of COVID-19 cases and deaths in  the United States: An ecological analysis - The Lancet Regional Health –  Americas
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis - The Lancet Regional Health – Americas

Is the Pfizer-BioNTech COVID vaccine still effective after 6 months?
Is the Pfizer-BioNTech COVID vaccine still effective after 6 months?

Interim Estimates of COVID-19 Vaccine Effectiveness Against  COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters  and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta)  Variant Predominance — Nine States, June–August ...
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August ...

Vaccines | Free Full-Text | Evaluating COVID-19 Booster Vaccination  Strategies in a Partially Vaccinated Population: A Modeling Study
Vaccines | Free Full-Text | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study

COVID Vaccination + Booster Information | Coronavirus Information
COVID Vaccination + Booster Information | Coronavirus Information

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children:  Updated Recommendations of the Advisory Committee on Immunization Practices  — United States, 2022 | MMWR
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR